Download PDF
Semin Reprod Med 2012; 30(05): 387-395
DOI: 10.1055/s-0032-1324722
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

WNT4, RSPO1, and FOXL2 in Sex Development

Anna Biason-Lauber
1   Department of Medicine, University of Fribourg, Fribourg, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
08 October 2012 (online)

    Permissions and Reprints

Abstract

The idea that the female sexual development happens by default was born in the middle of the last century after Jost performed his innovative experiments to study the bases of differentiation of the reproductive tract and found that the female reproductive tract develops even in the absence of any gonad. The term default (passive) attributed to the whole female developmental pathway, therefore, established itself, even if it was not originally so intended. However, recent developments have demonstrated that ovarian development is an active process. Wingless type MMTV integration site family, member 4 (WNT4), one of a few factors with a demonstrated function in the ovarian-determination pathway, has been found to be involved in sexual differentiation by suppressing male sexual differentiation, promoting Müllerian duct differentiation, and maintaining oocyte health. WNT4 expression in the ovary seems to be regulated by R-spondin 1 (RSPO1), a thrombospondin family member protein. The role and interactions of WNT4, RSPO1, and other factors such as forkhead transcription factor 2 in ovarian development and function will be discussed.

Keywords

ovarian differentiation - WNT4 - RSPO1
 

  • References

  • 1 McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M. A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci USA 1993; 90 (8) 3368-3372
    CrossrefPubMedSearch in Google Scholar
  • 2 He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004; 131 (8) 1663-1677
    CrossrefPubMedSearch in Google Scholar
  • 3 Nusse R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 2003; 130 (22) 5297-5305
    CrossrefPubMedSearch in Google Scholar
  • 4 Pandur P, Läsche M, Eisenberg LM, Kühl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002; 418 (6898) 636-641
    CrossrefPubMedSearch in Google Scholar
  • 5 Jääskeläinen M, Prunskaite-Hyyryläinen R, Naillat F , et al. WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival. Mol Cell Endocrinol 2010; 317 (1–2) 106-111
    CrossrefPubMedSearch in Google Scholar
  • 6 Jordan BK, Mohammed M, Ching ST , et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 2001; 68 (5) 1102-1109
    CrossrefPubMedSearch in Google Scholar
  • 7 Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999; 397 (6718) 405-409
    CrossrefPubMedSearch in Google Scholar
  • 8 Yao HH, Matzuk MM, Jorgez CJ , et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 2004; 230 (2) 210-215
    CrossrefPubMedSearch in Google Scholar
  • 9 Merchant H. Rat gonadal and ovarioan organogenesis with and without germ cells. An ultrastructural study. Dev Biol 1975; 44 (1) 1-21
    CrossrefPubMedSearch in Google Scholar
  • 10 McLaren A. Meiosis and differentiation of mouse germ cells. Symp Soc Exp Biol 1984; 38: 7-23
    PubMedSearch in Google Scholar
  • 11 Naillat F, Prunskaite-Hyyryläinen R, Pietilä I , et al. Wnt4/5a signalling coordinates cell adhesion and entry into meiosis during presumptive ovarian follicle development. Hum Mol Genet 2010; 19 (8) 1539-1550
    CrossrefPubMedSearch in Google Scholar
  • 12 Ottolenghi C, Pelosi E, Tran J , et al. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 2007; 16 (23) 2795-2804
    CrossrefPubMedSearch in Google Scholar
  • 13 Mandel H, Shemer R, Borochowitz ZU , et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am J Hum Genet 2008; 82 (1) 39-47
    CrossrefPubMedSearch in Google Scholar
  • 14 Domenice S, Corrêa RV, Costa EM , et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res 2004; 37 (1) 145-150
    CrossrefPubMedSearch in Google Scholar
  • 15 Biason-Lauber A, Konrad D, Navratil F, Schoenle EJA. A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. N Engl J Med 2004; 351 (8) 792-798
    CrossrefPubMedSearch in Google Scholar
  • 16 Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ. WNT4 deficiency—a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod 2007; 22 (1) 224-229
    PubMedSearch in Google Scholar
  • 17 Philibert P, Biason-Lauber A, Rouzier R , et al. Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab 2008; 93 (3) 895-900
    CrossrefPubMedSearch in Google Scholar
  • 18 Philibert P, Biason-Lauber A, Gueorguieva I , et al. Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril 2011; 95 (8) 2683-2686
    CrossrefPubMedSearch in Google Scholar
  • 19 Kamata T, Katsube K, Michikawa M, Yamada M, Takada S, Mizusawa H. R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants. Biochim Biophys Acta 2004; 1676 (1) 51-62
    CrossrefPubMedSearch in Google Scholar
  • 20 Kim KA, Kakitani M, Zhao J , et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005; 309 (5738) 1256-1259
    CrossrefPubMedSearch in Google Scholar
  • 21 Chassot AA, Gregoire EP, Magliano M, Lavery R, Chaboissier MC. Genetics of ovarian differentiation: Rspo1, a major player. Sex Dev 2008; 2 (4–5) 219-227
    CrossrefPubMedSearch in Google Scholar
  • 22 Chassot AA, Ranc F, Gregoire EP , et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum Mol Genet 2008; 17 (9) 1264-1277
    CrossrefPubMedSearch in Google Scholar
  • 23 Parma P, Radi O, Vidal V , et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 2006; 38 (11) 1304-1309
    CrossrefPubMedSearch in Google Scholar
  • 24 Tomaselli S, Megiorni F, De Bernardo C , et al. Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutation. Hum Mutat 2008; 29 (2) 220-226
    CrossrefPubMedSearch in Google Scholar
  • 25 Crisponi L, Deiana M, Loi A , et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001; 27 (2) 159-166
    CrossrefPubMedSearch in Google Scholar
  • 26 Cocquet J, Pailhoux E, Jaubert F , et al. Evolution and expression of FOXL2. J Med Genet 2002; 39 (12) 916-921
    CrossrefPubMedSearch in Google Scholar
  • 27 Pisarska MD, Bae J, Klein C, Hsueh AJ. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 2004; 145 (7) 3424-3433
    CrossrefPubMedSearch in Google Scholar
  • 28 Pannetier M, Fabre S, Batista F , et al. FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol 2006; 36 (3) 399-413
    CrossrefPubMedSearch in Google Scholar
  • 29 Ellsworth BS, Egashira N, Haller JL , et al. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 2006; 20 (11) 2796-2805
    CrossrefPubMedSearch in Google Scholar
  • 30 Pannetier M, Renault L, Jolivet G, Cotinot C, Pailhoux E. Ovarian-specific expression of a new gene regulated by the goat PIS region and transcribed by a FOXL2 bidirectional promoter. Genomics 2005; 85 (6) 715-726
    CrossrefPubMedSearch in Google Scholar
  • 31 Moumné L, Batista F, Benayoun BA , et al. The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol 2008; 282 (1–2) 2-11
    CrossrefPubMedSearch in Google Scholar
  • 32 Henderson ST, Johnson TE. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 2001; 11 (24) 1975-1980
    CrossrefPubMedSearch in Google Scholar
  • 33 Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci U S A 2007; 104 (9) 3330-3335
    CrossrefPubMedSearch in Google Scholar
  • 34 Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996; 62: 167-215
    PubMedSearch in Google Scholar
  • 35 Uhlenhaut NH, Jakob S, Anlag K , et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 2009; 139 (6) 1130-1142
    CrossrefPubMedSearch in Google Scholar
  • 36 Shah SP, Köbel M, Senz J , et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009; 360 (26) 2719-2729
    CrossrefPubMedSearch in Google Scholar
  • 37 Moumné L, Fellous M, Veitia RA. Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation. Hum Mol Genet 2005; 14 (23) 3557-3564
    CrossrefPubMedSearch in Google Scholar
  • 38 Moumné L, Dipietromaria A, Batista F , et al. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet 2008; 17 (7) 1010-1019
    PubMedSearch in Google Scholar
  • 39 Dipietromaria A, Benayoun BA, Todeschini AL, Rivals I, Bazin C, Veitia RA. Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems. Hum Mol Genet 2009; 18 (17) 3324-3333
    CrossrefPubMedSearch in Google Scholar
  • 40 Benayoun BA, Georges AB, L'Hôte D , et al. Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase. Hum Mol Genet 2011; 20 (9) 1673-1686
    CrossrefPubMedSearch in Google Scholar
  • 41 Liang L, Soyal SM, Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development 1997; 124 (24) 4939-4947
    PubMedSearch in Google Scholar
  • 42 Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 2004; 305 (5687) 1157-1159
    CrossrefPubMedSearch in Google Scholar
  • 43 Soyal SM, Amleh A, Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 2000; 127 (21) 4645-4654
    PubMedSearch in Google Scholar
  • 44 De La Chesnaye E, Kerr B, Paredes A, Merchant-Larios H, Méndez JP, Ojeda SR. Fbxw15/Fbxo12J is an F-box protein-encoding gene selectively expressed in oocytes of the mouse ovary. Biol Reprod 2008; 78 (4) 714-725
    CrossrefPubMedSearch in Google Scholar
  • 45 Su YQ, Sugiura K, Wigglesworth K , et al. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development 2008; 135 (1) 111-121
    PubMedSearch in Google Scholar
  • 46 Di Pasquale E, Rossetti R, Marozzi A , et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006; 91 (5) 1976-1979
    CrossrefPubMedSearch in Google Scholar
  • 47 Dixit H, Rao LK, Padmalatha VV , et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006; 119 (4) 408-415
    CrossrefPubMedSearch in Google Scholar
  • 48 Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 2007; 81 (3) 576-581
    CrossrefPubMedSearch in Google Scholar
  • 49 Palmer JS, Zhao ZZ, Hoekstra C , et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 2006; 91 (11) 4713-4716
    CrossrefPubMedSearch in Google Scholar
  • 50 Chand AL, Ponnampalam AP, Harris SE, Winship IM, Shelling AN. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril 2006; 86 (4) 1009-1012
    CrossrefPubMedSearch in Google Scholar
  • 51 Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE, Carson SA. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril 2007; 87 (1) 143-146
    CrossrefPubMedSearch in Google Scholar
  • 52 Harris SE, Chand AL, Winship IM, Gersak K, Aittomäki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002; 8 (8) 729-733
    CrossrefPubMedSearch in Google Scholar
  • 53 Britt KL, Findlay JK. Regulation of the phenotype of ovarian somatic cells by estrogen. Mol Cell Endocrinol 2003; 202 (1–2) 11-17
    CrossrefPubMedSearch in Google Scholar
  • 54 Couse JF, Hewitt SC, Bunch DO , et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999; 286 (5448) 2328-2331
    CrossrefPubMedSearch in Google Scholar
  • 55 Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127 (19) 4277-4291
    PubMedSearch in Google Scholar
  • 56 Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev 2008; 2 (4–5) 200-209
    CrossrefPubMedSearch in Google Scholar
  • 57 Hanley NA, Ball SG, Clement-Jones M , et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev 1999; 87 (1–2) 175-180
    CrossrefPubMedSearch in Google Scholar
  • 58 Murayama C, Miyazaki H, Miyamoto A, Shimizu T. Involvement of Ad4BP/SF-1, DAX-1, and COUP-TFII transcription factor on steroid production and luteinization in ovarian theca cells. Mol Cell Biochem 2008; 314 (1–2) 51-58
    CrossrefPubMedSearch in Google Scholar
  • 59 Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000; 67 (6) 1563-1568
    CrossrefPubMedSearch in Google Scholar
  • 60 Lourenço D, Brauner R, Lin L , et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 2009; 360 (12) 1200-1210
    CrossrefPubMedSearch in Google Scholar
  • 61 Jeays-Ward K, Hoyle C, Brennan J , et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 2003; 130 (16) 3663-3670
    CrossrefPubMedSearch in Google Scholar
  • 62 Kocer A, Reichmann J, Best D, Adams IR. Germ cell sex determination in mammals. Mol Hum Reprod 2009; 15 (4) 205-213
    CrossrefPubMedSearch in Google Scholar
  • 63 Combes AN, Spiller CM, Harley VR , et al. Gonadal defects in Cited2-mutant mice indicate a role for SF1 in both testis and ovary differentiation. Int J Dev Biol 2010; 54 (4) 683-689
    CrossrefPubMedSearch in Google Scholar
  • 64 Tomizuka K, Horikoshi K, Kitada R , et al. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet 2008; 17 (9) 1278-1291
    CrossrefPubMedSearch in Google Scholar